Pierre Coulie
Scientific Advisory Board
Bg Enterprises Inc
Romania
Biography
His current work is focused on human anti-tumor immunology in the context of therapeutic vaccination using tumor-specific antigens, with specific work aiming at understanding the mechanisms of tumor regression observed in some vaccinated melanoma patients, and the reasons for clinical vaccine failure in most patients.In 1988, he joined the group of Prof. Thierry Boon and switched to human immunology. Investigator at the Brussels branch of the Ludwig Institute for Cancer Research from 1989 to 1995, he made important contributions to the identification of human tumor-specific antigens recognized by T lymphocytes. Pursuing his collaboration with the neighbouring teams of the Ludwig Institute, he is primarily interested in human anti-tumor immunology. Prof. Pierre G. Coulie is a Professor at the Faculty of Medicine of the Université Catholique de Louvain (UCL). Trained in immunology as a student by Prof. Jacques Van Snick, he worked on murine rheumatoid factors and on cytokines
Research Interest
immunology
